NouvNeu001 Injection
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NouvNeu001 Injection, covering 2026-04-14 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery [Phase 1]